Basic Information
| LncRNA/CircRNA Name | GACAT2 |
| Synonyms | HMlincRNA717, GACAT2, MTCL1-AS1, MTCL1AS1 |
| Region | GRCh38_18:8695856-8707621 |
| Ensemble | ENSG00000265962 |
| Refseq | NR_120598 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | plasma |
| Expression Pattern | up-regulated |
| Function Description | The results demonstrated that plasma GACAT2 levels in preoperative patients with GC were significantly higher than those in the postoperative group. Compared with healthy individuals, plasma GACAT2 levels were significantly increased in patients with GD and preoperative patients with GC. Moreover, the individual relative changes of plasma GACAT2 expression following surgery were significantly associated with lymphatic metastasis, distal metastasis and perineural invasion. |
| Pubmed ID | 28105191 |
| Year | 2016 |
| Title | Plasma lncRNA-GACAT2 is a valuable marker for the screening of gastric cancer. |
External Links
| Links for GACAT2 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |